COVID-19: progression of disease and intravascular coagulation – present status and future perspectives

What is it about?

The timely and accurate diagnosis of infection with severe acute respiratory syndrome [SARS] coronavirus 2 [SARS-CoV-2], the cause of COVID-19, remains the cornerstone of efforts to provide appropriated treatment for patients, to limit further spread of the virus and ultimately to eliminate the virus from human society. An important therapeutic options is anticoagulant treatment with heparin and low-molecular weight heparin and control by D-dimer as marker of activated blood coagulation.

Featured Image